Delivery Order SPE2DB20D1100-SPE2DB24FC3U7
Award Date
6/21/24
Potential Completion Date
6/24/24
Potential Value
$87K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,442.89 contract is for the delivery of Mesalamine 800 mg delayed-release tablets. The contract is a firm fixed-price type with an ultimate completion date of October 25, 2022. This award is not associated with a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Mesalamine 800 mg delayed-release tablets, a medication used to treat inflammatory bowel diseases. The award has a ceiling value of $4,517.65 and a completion date of June 13, 2024.
Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Mesalamine 800 mg delayed-release tablets. The $13,126.28 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has a period of performance through September 16, 2024 and does not have a set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) vehicle the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of Mesalamine 800 mg delayed-release tablets, a pharmaceutical product used to treat gastrointestinal conditions.
The award has a ceiling value of $17,230.65 and an ultimate completion date of September 4, 2024. The contract is a firm-fixed-price type, with no set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,497.63 firm fixed price contract is for the delivery of 120 tablets of 1.2 gram Mesalamine delayed-release medication. The contract has an ultimate completion date of January 19, 2023.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Mesalamine 800 mg delayed-release tablets over a one-year period. The award, made by the Defense Logistics Agency (DLA), is a firm-fixed price delivery order with a ceiling value of $16,829.06. The contract has no set-aside designation.
Amerisourcebergen is a major pharmaceutical distribution company that holds several indefinite delivery contracts (IDCs) with federal agencies, including a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $14,279.26 contract is for the delivery of 180 count bottles of 800 mg delayed-release mesalamine tablets. This delivery order falls under a much larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of 4,565,735,562 units of Mesalamine 800 mg delayed-release tablets, with a total ceiling value of $11,104.93. The contract has a period of performance through September 10, 2024 and is a Firm Fixed Price, Delivery Order type contract. This award is not associated with a set-aside program. AmerisourceBergen, a major...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of 800 mg delayed-release (DR) mesalamine tablets. The $7,350.77 firm fixed price order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 for the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical and medical supplies to support military treatment facilities and programs worldwide. The contract does not have a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to supply Mesalamine delayed-release tablets to the U.S. government. The contract has a ceiling value of $1,858.33 and a period of performance through April 29, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA valued...